Latest Articles about MDT

Study for STJ's Latest EnligHTN - Analyst Blog

Zacks Equity Research — Wed, 15 May 2013 17:06:19 Z

St. Jude Medical Inc. ( STJ ) has initiated the EnligHTN III trial with the enrollment of the first patient to evaluate its latest, second-generation EnligHTN Renal Denervation System in

Diamond Hill Capital Update and Top Three

Sally Jones — Wed, 15 May 2013 00:03:57 Z

Founded in year 2000, Diamond Hill Capital Management lists assets under management of $10.7 billion, as of April 30, 2013. Independent and publicly owned, Diamond Hill is listed on Nasdaq (

Earnings Miss at UTHR - Analyst Blog

Zacks Equity Research — Mon, 29 Apr 2013 18:04:08 Z

United Therapeutics Corp. ( UTHR ) reported first-quarter 2013 earnings of $1.19 per share, well below the year-ago earnings of $1.29 and the Zacks Consensus Estimate of $1.47. First

Greatbatch 1Q Earnings Beat Ests; Sales Dip - Analyst Blog

Zacks Equity Research — Fri, 26 Apr 2013 23:30:01 Z

Greatbatch, Inc. 's ( GB ) first-quarter 2013 adjusted earnings per share (excluding one-time expenses) of 44 cents beat the Zacks Consensus Estimate by a penny. It also exceeded the

20 Dividend Champions With Highest 10-Year Dividend Growth Rates

Trefis Team — Fri, 26 Apr 2013 21:49:07 Z

Submitted by Dividend Yield as part of our contributors program . Dividend Champions with fastest 10 year dividend growth originally published at " long-term-investments.blogspot.com

Edwards Lags on Earnings & Rev - Analyst Blog

Zacks Equity Research — Wed, 24 Apr 2013 18:14:58 Z

Edwards Lifesciences Corporation's ( EW ) first-quarter 2013 adjusted earnings per share (EPS) came in at 72 cents, up 35.8% year over year, but lagging the Zacks Consensus Estimate of 76

Earnings Acceleration Can Forecast Big Moves Ahead - Screen of the Week

Kevin Matras — Tue, 23 Apr 2013 11:15:01 Z

In good markets or bad, earnings are one of the most important things that influence stock prices. But instead of just looking at only the most recent quarter's earnings, try looking for

Closing Update: Stocks Overcome Caterpillar, Housing Sale Disappointments to End Moderately Higher

MidnightTrader.com Staff — Tue, 23 Apr 2013 00:09:48 Z

U.S. stocks overcame disappointing guidance from Caterpillar and an unexpected dip in existing home sales to finish higher Monday. Energy and materials stocks led the markets higher, rebounding

CE Mark for STJ's DBS Offering - Analyst Blog

Zacks Equity Research — Thu, 11 Apr 2013 18:12:43 Z

Medical devices giant, St. Jude Medical ( STJ ) has won CE Mark approval for its Brio Libra and LibraXP deep brain stimulation ("DBS") product line. The devices are intended to

MDT to Grow Endovascular Biz Globally - Analyst Blog

Zacks Equity Research — Mon, 08 Apr 2013 23:10:11 Z

Medtronic Inc. ( MDT ) has further strengthened its endovascular portfolio. The company, with the receipt of CE Mark approval for the Sentrant Introducer Sheath, will be launching this

Medtronic Remains at Neutral - Analyst Blog

Zacks Equity Research — Fri, 05 Apr 2013 22:09:12 Z

We recently reinstated our Neutral recommendation on Medtronic, Inc. ( MDT ), a leading medical devices company. While we are to-some-extent relieved with the signs of stability in

FDA Clears Affinity, Boosts MDT's Biz - Analyst Blog

Zacks Equity Research — Wed, 03 Apr 2013 22:22:09 Z

The recent US Food and Drug Administration ("FDA") 510(k) clearance for Affinity Fusion oxygenation system has enhanced the structural heart business of medical devices major -

Medtronic, Inc. (MDT) Ex-Dividend Date Scheduled for April 03, 2013

NASDAQ.com News — Tue, 02 Apr 2013 17:00:03 Z

Medtronic, Inc. ( MDT ) will begin trading ex-dividend on April 03, 2013. A cash dividend payment of $0.26 per share is scheduled to be paid on April 26, 2013. Shareholders who purchased MDT

Greatbatch Reiterated at Neutral - Analyst Blog

Zacks Equity Research — Thu, 28 Mar 2013 22:24:50 Z

On Mar 27, we retained Greatbatch, Inc. ( GB ) at Neutral, following its mixed fourth-quarter results. Although it managed to grow at a double-digit rate in the quarter in terms of both the

Weekly Healthcare Note: Abbott Labs And Intuitive Surgical

Trefis Team — Wed, 27 Mar 2013 17:26:07 Z

The past week has been eventful for the healthcare sector. During the week, Abbott Labs ( ABT ) got conflicting responses relating to the pending approval of MitraClip. While the FDA staff